Has Michael Musacchio, MD received payments from drug or device companies?

Yes. Drug and device makers reported $795,571 in general payments to Michael Musacchio, MD across 340 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Musacchio, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Musacchio, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Musacchio, MD

Neurological Surgery · Evanston, ILNPI 1306036876

Payments from drug & device makers

$795,571in general payments, 2019–2025

Across 340 payments — averaging $2339.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intrinsic Therapeutics$207K
Medtronic$191K
Spineart USA Inc$174K
Globus Medical$111K
Spineart SA$103K
Surgalign Spine Technologies, Inc.$5K
plus $5K from 5 others

$35,866in research payments, 2019–2025

Across 5 payments — averaging $7173.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Intrinsic Therapeutics$36K

What the payments were for

Consulting fees$57,94021%
Speaking & faculty fees$190,16469%
Travel & lodging$18,0167%
Food & beverage$7,9833%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intrinsic Therapeutics	107	$206,792
Medtronic(2 entities)	164	$190,708
Spineart USA Inc	3	$173,826
Globus Medical(2 entities)	41	$111,205
Spineart SA	10	$103,410
Surgalign Spine Technologies, Inc.	3	$4,768
Centinel Spine, LLC	3	$4,189
Axis Spine Technologies Inc.	2	$411
Providence Medical Technology, Inc.	2	$134
Aesculap Implant Systems, LLC	4	$95
Johnson & Johnson	1	$33

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

BARRICAID ACD (ANNULAR CLOSURE DEVICE)$89,617
PIVOX Oblique Lateral Spinal System$62,389
CD HORIZON SPINAL SYSTEM$34,358
Barricaid Annular Closure Device$22,760
CRESCENT$18,681
CD HORIZON$14,684
DIVERGENCE-L ANTERIOR/OBLIQUE LUMBAR FUSION SYSTEM$9,550
DIVERGENCE-L$7,765
Simplify Cervical Artificial Disc$4,857
STEALTHSTATION S8 PLATFORM$3,713
INFINITY OCCIPITOCERVICAL UPPER THORACIC SYSTEM$3,250
O-ARM-ST$2,500
CAPSTONE$1,455
Perla TL$605
GRAFTONAND GRAFTON PLUSDEMINERALIZED BONE MATRIX (DBM)$437
AXIS-ALIF$375
POWEREASE INSTRUMENTS$220
MAZOR X SYSTEM$198
Mazor X Stealth Edition$170
CATALYFT PL EXPANDABLE INTERBODY SYSTEM$144

How this compares

$795,571 in reported general payments places this provider in the 95th percentile of 302 neurological surgery providers in Illinois.

See all neurological surgery providers in Illinois →

Medicare billing

Part B allowed, 2024

$592,028

Medicare patients

628

Services billed

1,472

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	53	$607
Celecoxib	28	$591
Methylprednisolone	78	$392
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	33	$361
Tizanidine Hcl	40	$292
Mupirocin	36	$238
Tramadol Hcl	18	$42
Meloxicam	22	$35

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Evanston

Julian BailesEvanston$666K
William AresEvanston$98K
Tyler KoskiChicago$2.3M
Vincent TraynelisChicago$1.8M
Sergey NeckryshChicago$1.6M
Russell NockelsArlington Heights$1.4M
Bruce FrankelSpringfield$1.3M
Richard FesslerChicago$924K
Sandi LamChicago$914K
John OtooleChicago$745K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →